'Pharma Bro' Martin Shkreli Tells Critics 'Do Not Make Fun of Me' As Opendoor Short Sours Amid Rate-Cut Rally: 'That Is Inappropriate'
Investor Martin Shkreli, popularly known as "Pharma Bro," pushed back against criticism on this recent short position on iBuying platform Opendoor Technologies Inc. (NASDAQ: OPEN), which is rallying amid the Federal Reserve's rate cuts on Wednesday.